What's breaking now, across thousands of outlets.
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer and Merck on nearly all bacterial strains in the first of three Phase 3…
Russian officials insist the situation is under control after reports a lab technician died of plague in Siberia, saying post-mortem tests found no trace.
Russian officials insist the situation is under control after reports a lab technician died of plague in Siberia, saying post-mortem tests found no trace.
Pharmacists warn that common medicine mistakes, from incorrect doses and sharing prescriptions to stopping treatment early, can lead to serious health complications, while patients are urged to avoid…
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly…
Speculation has surrounded the death of Daria Shipilova, who worked in a plague research center in Irkutsk.
